TOP HEADLINES

Featured Story

Novartis combo therapy for COPD shows promise in clinical trials, awaits FDA approval

Novartis announced that its investigational combination indacaterol/glycopyrronium bromide therapy for COPD performed better than its constituent components in a Phase III clinical trial.

Data-gathering insulin pen maker Companion pulls in Series B led by Eli Lilly

Companion Medical, a California startup with a Bluetooth-enabled insulin pen and smartphone app, pulled in Series B financing this week, led by Big Pharma player Eli Lilly. Though the amount was undisclosed, the move marks a step forward for Lilly into the world of drug delivery technology, for which the company is currently building an R&D center in Cambridge, MA.

Pacira's liposomal-encased bupivacaine gets positive reviews at breast cancer conference

Pacira's liposomal-encased bupivacaine medication was touted at the annual Miami Breast Cancer Conference as an effective postoperative pain reliever following breast removal or reconstruction.

Nanoparticles tagged with amino acids help diagnose glioblastoma to someday target drugs

Researchers in Japan have published a study in the journal Science and Technology of Advanced Materials demonstrating greater potential for nanoparticles that can both carry drugs and act as imaging targets to diagnose malignant tumors in the brain.

FDA approves long-acting formulation of J&J schizophrenia med

The FDA gave the green light to Johnson & Johnson's Invega Trinza, which is injected four times a year, making it the longest-acting schizophrenia drug on the market.

MORE NEWS

From Our Sister Sites

FierceBiotech

Bristol-Myers Squibb and rival Merck started off the big annual scientific meeting of  ASCO  with a bang, rolling out a slate of new studies spotlighting the growing body of evidence that their new immuno-oncology drugs will play a key role fighting a range of cancers.

FierceAnimalHealth

Danish enzyme maker Novozymes is answering the call for alternatives to animal antibiotics by entering the market for probiotics--the so-called good bacteria that are believed to boost growth and prevent the buildup of bad bugs in animals' guts.